J&J hires Goldman to explore sale of Splenda, say sources-Reuters

Johnson & Johnson (JNJ.N), the U.S.-based healthcare company, has hired Goldman Sachs (GS.N) to explore a sale of its artificial sweetener brand Splenda, sources told Reuters.

DealsNorth AmericaUS